Skip to main content
PLOS One logoLink to PLOS One
. 2021 Oct 11;16(10):e0258515. doi: 10.1371/journal.pone.0258515

How does individualised physiotherapy work for people with low back pain? A Bayesian Network analysis using randomised controlled trial data

Bernard X W Liew 1,*, Jon J Ford 2, Marco Scutari 3, Andrew J Hahne 2
Editor: Walid Kamal Abdelbasset4
PMCID: PMC8504753  PMID: 34634071

Abstract

Purpose

Individualised physiotherapy is an effective treatment for low back pain. We sought to determine how this treatment works by using randomised controlled trial data to develop a Bayesian Network model.

Methods

300 randomised controlled trial participants (153 male, 147 female, mean age 44.1) with low back pain (of duration 6–26 weeks) received either individualised physiotherapy or advice. Variables with potential to explain how individualised physiotherapy works were included in a multivariate Bayesian Network model. Modelling incorporated the intervention period (0–10 weeks after study commencement–“early” changes) and the follow-up period (10–52 weeks after study commencement–“late” changes). Sequences of variables in the Bayesian Network showed the most common direct and indirect recovery pathways followed by participants with low back pain receiving individualised physiotherapy versus advice.

Results

Individualised physiotherapy directly reduced early disability in people with low back pain. Individualised physiotherapy exerted indirect effects on pain intensity, recovery expectations, sleep, fear, anxiety, and depression via its ability to facilitate early improvement in disability. Early improvement in disability, led to an early reduction in depression both directly and via more complex pathways involving fear, recovery expectations, anxiety, and pain intensity. Individualised physiotherapy had its greatest influence on early change variables (during the intervention period).

Conclusion

Individualised physiotherapy for low back pain appears to work predominately by facilitating an early reduction in disability, which in turn leads to improvements in other biopsychosocial outcomes. The current study cannot rule out that unmeasured mechanisms (such as tissue healing or reduced inflammation) may mediate the relationship between individualised physiotherapy treatment and improvement in disability. Further data-driven analyses involving a broad range of plausible biopsychosocial variables are recommended to fully understand how treatments work for people with low back pain.

Trials registration

ACTRN12609000834257.

Introduction

Understanding how treatments work for people with low back pain (LBP) allows therapists to target factors most likely to facilitate recovery [1]. It is hypothesised that persistent low back pain is driven by a range of complex mechanisms that are not fully understood [2, 3]. Research has highlighted the potential importance of biological (eg. pathoanatomical [4], sleep [5]), psychological (eg. anxiety [6], catastrophizing [7]), and social factors such as work engagement [8]. Treatments that target a single mechanism of effect have typically demonstrated small and temporary treatment effects at best for people with LBP [9, 10]. Treatments such as stratified or individualised physiotherapy provide the opportunity to target multiple mechanisms of effect to optimise treatment outcomes [11, 12]. Randomised controlled trials (RCTs) of stratified [13] and individualised [1416] physiotherapy have demonstrated small but promising effects in the treatment of people with LBP. Understanding the potential mechanisms driving short and long-term treatment effects provides an opportunity to better target treatment for individuals with LBP.

Previous research has used linear regression or structural equation modelling to evaluate how individualised [17] or stratified [18] physiotherapy might work for people with low back pain. These models examined the influence of hypothesised mediators (pain intensity, catastrophising, fear, anxiety, depression, stress, self-efficacy, coping and sleep) on the outcomes of pain and disability [17, 18]. A limitation of these previous mediation analyses is that structural assumptions must be made around the direction of mediation (eg. that psychosocial factors mediate disability but not vice-versa [17, 18]). In addition, previous mediation analyses have not allowed for mediators to influence each other [17, 18], like the sequential path of the fear-avoidance model (FAM) [19]. The recovery pathways underpinning the effects of individualised treatment for LBP could feasibly involve multiple interacting relationships between variables and the direction of those relationships may not be definitively known.

Bayesian Networks (BN) [20] are a class of probabilistic network modelling that provide a data-driven approach to derive complex pathways of effects. Unlike hypothesis-driven methods such as structural equations modelling (SEM) (e.g. in [21]), and simple mediation analysis (e.g. in [17]) that enforce a fixed structure, BN do not need to impose structural assumptions on the data informed by prior knowledge. BN may therefore reveal new relationships that have not been previously hypothesised. BN have previously been used to determine recovery pathways for some musculoskeletal disorders including whiplash [22] and postoperative cervical radiculopathy [23], but not for individuals with LBP.

To explore how treatments work for people with LBP using a BN approach, data from a large randomised controlled trial is required. The Specific Treatment of Problems of the Spine (STOPS) Trial was a large RCT (n = 300) which showed that individualised physiotherapy was more effective than advice for people with LBP [16]. As a treatment informed by the biopsychosocial approach, several plausible recovery pathways could have underpinned the benefits of individualised physiotherapy. The aim of this study was to determine how the individualised physiotherapy (relative to the advice) approach in the STOPS RCT helped people with LBP.

Materials and methods

Study design

This Bayesian Network analysis was undertaken using data from the STOPS trial, which was a multicentre, parallel-group, randomised controlled trial completed in Melbourne, Australia. The STOPS trial enrolled 300 participants with LBP and has been reported previously [16, 24]. The trial was registered ACTRN12609000834257. The La Trobe University Human Ethics Committee approved the trial protocol [24]. All participants provided written informed consent to participate in the trial.

Participants

To be included in the trial, participants needed to have a current episode of low back pain (and/or referred leg pain) between 6 weeks and 6 months duration, be aged 18–65 years and speak English [16]. Exclusion criteria were: a compensation claim, serious pathology (active cancer, cauda equine syndrome, foot drop making walking unsafe), pregnancy or childbirth within the last 6 months, history of lumbar spine surgery, spinal injections in the past six weeks, pain intensity < 2/10 or minimal activity limitation.

Interventions (10 weeks)

Participants were randomised (via an offsite randomisation service) to receive either individualised physiotherapy (n = 156) or guideline-based advice (n = 144). Treatment was administered over a 10-week period. Participants were then discharged to independent self-management, but had outcomes followed up at 52 weeks.

Guideline based advice

Participants allocated to guideline-based advice received 2 x 30-minute sessions over a 10-week period based on the approach described previously [25]. This included an explanation of the hypothesized source of the participant’s pain, reassurance regarding a favourable prognosis, advice to remain active, and instruction regarding appropriate lifting techniques [24].

Individualised physiotherapy

Participants allocated to the individualised physiotherapy group received 10 x 30-minute physiotherapy sessions over a 10-week period. Physiotherapy was individualised based on the patient’s presentation. Available treatment components included pathoanatomical or neurophysiological information, education, self-management strategies (posture, pacing, pain management, sleep management, relaxation strategies), inflammatory management strategies (anti-inflammatory medication, taping, avoidance of provocative movements/postures), exercise (specific muscle activation, goal-oriented graded activity/exercise), manual therapy, directional preference management, and cognitive-behavioral strategies. Full details of the treatment protocols have been published previously [24, 2629].

Variables included in the Bayesian Network

The treatment group (individual physiotherapy or advice) was included in the BN as this was the variable upon which participants were randomised. Other variables were chosen for inclusion in the BN if they were measured at baseline and at 10 and 52-week follow-up (allowing change scores to be computed), and could feasibly act as predictors, mediators, or outcomes based on previous literature (see Introduction). Variables 5–11 below represented values from the individual items of the Örebro Musculoskeletal Pain Questionnaire (Örebro) [30]. Using single-item questions to quantify psychological features has been applied in previous studies on LBP for clinical subgrouping [31], and prognosis [32], and there is evidence of strong concurrent validity for single-item questions against full questionnaires in this population [33]. In addition, the single-item measurement strategy has been used in similar network studies in individuals with chronic pain [34], and in the broader field of psychology [35]. The following variables were used to form a BN:

  1. Group: the randomised allocation into the two treatment arms (individualised physiotherapy versus advice).

  2. Disability: Oswestry Disability Index [36]. The score ranges from 0 (no disability) to 100 (maximal disability).

  3. LBP intensity: Measured on the 0–10 numerical rating scale (NRS). The score ranges from 0 (no pain) to 10 (worst pain possible).

  4. Leg pain intensity: Measured on the 0–10 numerical rating scale (NRS). The score ranges from 0 (no pain) to 10 (worst pain possible).

  5. Pain coping: Question of the Örebro [30], “Based on all the things you do to cope, or deal with your pain, on an average day, how much are you able to decrease it”? The score ranges from 0 (can decrease completely) to 10 (cannot decrease at all).

  6. Pain persistence (recovery expectations): Question of the Örebro [30], “In your view, how large is the risk that your current pain may become persistent? The score ranges from 0 (no risk) to 10 (very large risk).

  7. Depressive symptoms: Question of the Örebro [30], “How much have you been bothered by feeling depressed in the past week? The score ranges from 0 (not at all) to 10 (extremely).

  8. Anxiety symptoms: Question of the Örebro [30], “How tense or anxious have you felt in the past week? The score ranges from 0 (not at all) to 10 (extremely).

  9. Work expectations: Question of the Örebro [30], “In your estimation, what are the chances that you will be working in 6 months?. The score ranges from 0 (very large chance) to 10 (no chance).

  10. Fear-avoidance beliefs: A summed total of the three fear-avoidance beliefs questions of the Örebro [30]. The total score ranges from 0 (no fear) to 30 (maximum fear)– 10 points per question.

  11. Sleep: Question 24 of the Örebro [30]. “I can sleep at night” Question scoring was inverted so that score ranges from 0 (can do it without pain being a problem) to 10 (cannot do it because of pain).

To quantify changes over time in variables 2 to 11, we coded time in the following manner:

  1. Early changes (during the intervention period): The values at week 10 were subtracted from the values at baseline (week 10 minus baseline), and the resultant variables were suffixed with “_early”.

  2. Late changes (following discharge from treatment): The values at week 52 were subtracted from the values at week 10 (week 52 minus week 10), and the resultant variables were suffixed with “_late”.

Statistical analysis

Bayesian network analysis

All analyses were performed in R software using the “bnlearn” package [37], with codes and results included in a public online repository [38]. BN is a graphical modelling technique [20] used increasingly in the health sciences to understand causal relationships. BN can handle some missing data [39], which makes them practical in longitudinal studies where data sets are often incomplete. Analogous to multivariate regression modelling, BN quantifies the relationships among a set of variables, but BN also uses a directed acyclic graph (DAG) to visually depict the model. In BN modelling, each variable (or “node”) can be statistically associated with one or more other nodes, with conditional dependencies between nodes termed “arcs”. Building a BN model using a data-driven approach involves two stages: 1) structure learning—identifying relevant arcs; and 2) parameter learning—estimating the parameters that regulate the strength and direction of relationships between nodes.

BN can include prior knowledge, sourced from the literature and experts, during the model building process. To avoid imposing unproven assumptions on the model, we only built-in constraints that were undebatable (e.g. late change scores cannot influence early change scores, and early change scores cannot influence treatment group allocation). We allowed variables within the same time period to influence each other, consistent with previous studies [21, 40].

We made use of model averaging to reduce the potential of including spurious relationships in the BN, using bootstrap resampling (B = 200) and performing structure learning on each of the resulting samples using Structural Expectation-Maximization (EM) [39]. Structural EM is a technique that can build BN models in the presence of missing data [39]. It does so by building an initial empty BN model using the original complete data, using it to impute missing data, and then repeatedly rebuilding the BN model using the imputed data sets until convergence occurs. We computed an “average” consensus DAG by selecting arcs that were present in > 50% of the bootstrapped samples, to create a sparse and interpretable network [41].

To determine the validity (how well the model fitted the data) of the trained model, validation was performed using nested 10-fold cross-validation (CV). This splits the training set into 10 approximately equal folds, trains the model on 9 folds using bootstrap resampling (as described above), and evaluates the model’s performance on the 10th fold. A nested 10-fold CV reduces the likelihood of overestimating the validity of the model, given that the same data used for training the model was also not used for validating it. Model validity was defined by computing the Pearson correlation coefficient between the predicted and observed values of each continuous variable, which is the predictive equivalent of the traditional R2 fit index used in multiple regression. The strength of correlation was categorized as negligible (|r| ≤ 0.30), low (|r| = 0.31 to 0.50), moderate (|r| = 0.51 to 0.70), high (|r| = 0.71 to 0.90) and very high (|r| = 0.91 to 1) [42]. The greater the model’s predictive performance, the greater the correlation between the predicted and the observed values of the modelled variables. We also calculated the mean absolute error (MAE) (average of the absolute difference between the actual and predicted values), mean squared error (MSE) (average of the squared difference between the original and predicted values), and root-mean-squared error (RMSE) (square root of MSE), between the observed and predicted values.

Probing the network

Similar to other statistical models, BNs can be used to answer questions about the nature of the data that go beyond mere descriptive observations. In prognostic modelling, prediction of an outcome and its uncertainty is desired based upon knowing the values of the predictors. Similar to prognostic modelling, BNs can be used to elicit the range of plausible values a variable can take upon knowing the values of the surrounding variables–and this is called conditional probability query. For each conditional probability query, we sampled 104 data points of the variables of interest to obtain precise probability estimates, using a technique known as “logic sampling” [20].

Missing data management

Eleven participants (3.6%) had missing data in > 50% of the 21 variables, and were excluded from analysis, leaving 289 participants for network modelling. Imputation methods for multivariate models may become less accurate with large numbers of missing variables, hence we excluded this small number of participants who had large amounts of missing data [43]. The proportion of missing data per variable in these remaining participants are included in the (S1 Fig).

Results

The mean (SD) values for the baseline demographics, pain, and psychological characteristics are found in Table 1. All continuous change variables used for BN analysis are reported in Fig 1, whilst the raw mean values of these variables at the three time points (baseline, 10 and 52 weeks) can be found in the (S2 Fig).

Table 1. Baseline descriptive characteristics of cohort included in Bayesian Network analysis.

Baseline variable Advice (n = 137) Individualized PT (n = 152) Missing-excluded (n = 11) P.value
Age(years) 44.69(12.33) 42.67(12.02) 44.19(11.75) 0.368
Sex-Female* 67 74 6 0.931
Sex-Male* 70 78 5 0.931
Weight(kg) 77.41(15.79) 77.26(17.77) 174.38(6.07) 0.195
Height(cm) 169.97(11.52) 172.24(10.47) 74.7(8.93) 0.885
Disability 29.71(13.25) 29.31(11.85) 26.82(5.78) 0.750
Low back pain intensity 5.48(1.94) 5.29(1.97) 4.77(1.47) 0.415
Leg pain intensity 4.76(2.62) 4.58(2.74) 4.8(2.49) 0.860
Pain coping 5.06(2.15) 5.16(2.37) 4.36(2.38) 0.526
Anxiety 5.08(2.5) 4.62(2.58) 4(3.52) 0.183
Depression 3.54(2.98) 3.01(2.98) 3.64(3.5) 0.312
Pain persistence 7.26(2.17) 6.74(2.36) 6.55(3.17) 0.128
Work expectations 2.01(3.24) 1.63(2.95) 5.36(4.18) 0.001
Sleep 3.69(2.54) 3.57(2.49) 3.45(2.5) 0.893
Fear 18.11(6.01) 18.58(6.17) 22.6(6.13) 0.081

Abbreviations: PT–physiotherapy.

*—variables represent counts of participants. All other values reflect mean (one standard deviation).

P values for continuous variables derived from a one-way Analysis of Variance test, count variable from a Chi-squared Test.

Fig 1. Mean with error bars (one standard deviation) of the change values of each modelled variable in the Bayesian Network.

Fig 1

Abbreviation: Suffix with “_early”–change score between baseline and week-10 follow-up; “_late”–change value between week-10 and week-52; Anx—anxiety; lbp–low back pain; lp–leg pain; IndvPT–individualised physiotherapy.

Fig 2 shows the averaged BN consensus model learnt from 200 networks constructed from the data, with arcs depicted if they appeared in > 50% of the networks. A BN graph can be qualitatively interpreted like the graph of a SEM (e.g. [21]) and a DAG of a typical three-variable mediation model (e.g. [44]). The predictive correlations for all variables are included in Table 2, which varied from low (late change value of work expectations) to high (late change value of disability).

Fig 2. The directed acyclic graph (DAG) underlying the consensus Bayesian Network learned from the variables across 289 participants.

Fig 2

The colour of the arcs reflect the sign (positive [blue] or negative [red]) of the β coefficient value relating the “parent” to “child” variables. The thickness of the arcs reflects the proportion of times each arc was found in the 200 Bayesian Network models built; only arcs that appeared in >50% of the networks are included in the final averaged consensus network. Abbreviation: Suffix with “_early”–change score between baseline and week-10 follow-up; “_late”–change value between week-10 and week-52; Anx—anxiety; lbp–low back pain; lp–leg pain; IndvPT–individualised physiotherapy.

Table 2. Measurement errors between observed and predicted change values.

Variable Correlation Correlation strength RMSE MSE MAE
disability_early 0.72 high 9.2 85.4 7.2
lbp_early 0.68 moderate 1.8 3.4 1.4
lp_early 0.71 high 1.9 3.5 1.4
pain_cope_early 0.52 moderate 2.6 7.2 2.1
sleep_early 0.53 moderate 1.9 3.8 1.5
work_expect_early 0.44 low 2.1 4.7 1.6
pain_persist_early 0.62 moderate 2.4 5.9 1.9
anx_early 0.76 high 2.0 4.4 1.2
depress_early 0.69 moderate 2.3 5.4 1.8
fear_early 0.55 moderate 5.7 32.1 4.3
disability_late 0.73 high 8.2 68.8 6.2
lbp_late 0.71 high 1.6 2.5 1.2
lp_late 0.70 moderate 1.7 3.1 1.2
pain_cope_late 0.46 low 2.6 6.8 1.8
sleep_late 0.59 moderate 1.7 3.1 1.2
work_expect_late 0.42 low 1.6 2.7 1.1
pain_persist_late 0.65 moderate 2.6 7.0 1.9
anx_late 0.74 high 1.9 4.0 1.0
depress_late 0.65 moderate 1.7 2.9 1.1
fear_late 0.53 moderate 5.0 25.4 3.8

Abbreviation: Suffix with “_early”–change score between baseline and week-10 follow-up; “_late”–change value between week-10 and week-52; Anx—anxiety; lbp–low back pain; lp–leg pain; RMSE–root-mean-squared error; MSE- mean squared error; MAE- mean absolute error.

An advantage of BNs is that the model enables the reader to query different elements of the system to fully understand the interaction between variables. By systematically fixing the individual values of some variables from the model, the impact of those variables on the remaining variables in the model becomes clearer. This is akin to the concept of covariate adjustment in traditional multiple regression analysis. For simplicity, the magnitude of relationship between variables are reported using β coefficients, which can be interpreted as a one-unit change in the independent variable resulting in a β unit change in the dependent variable. The β coefficients can be interpreted similar to the path coefficients used in SEM. As the BN model was complex with multiple interconnected variables, we explore in more detail below three main findings that were of most relevance to understanding the recovery pathways in people with LBP receiving individualised physiotherapy versus advice.

Individualised physiotherapy worked predominately by facilitating early changes in disability

The BN showed that individualised physiotherapy exerted direct treatment effects on early change in disability and early change in pain coping (Fig 2). Individualised physiotherapy also indirectly improved back pain intensity, recovery expectations, sleep, fear, anxiety and depression via its influence on early change in disability. For example, individualised physiotherapy resulted in a 0.42 unit greater early reduction in LBP intensity than advice (t = -8.68, P < 0.001), but this relationship was dependent on early change in disability. When we simulated a scenario where the treatment group-to-early disability pathway was removed by fixing the value of the early disability regression coefficient to zero, there was no remaining difference between the treatment groups in early reduction in LBP (t = 1.15, P = 0.249). The influence of individualised physiotherapy on early change in LBP was therefore dependent on an early change in disability.

Pathways from early change in disability to early change in depression

A one-unit early reduction in disability resulted in a βdisabilityearlydepressearly = 0.045 unit early reduction in depression (t = 20.38, P < 0.001) (Fig 3). From Fig 2, it can be observed that this relationship was dependent on three variables: early changes in fear, LBP intensity, and pain persistence. When the value of each of the three aforementioned regression coefficients were sequentially fixed to zero, the βdisabilityearlydepressearly coefficient changed to 0.042 (when fixing fear_early, t = 19.23, P < 0.001), 0.038 (when fixing LBP_early, t = 17.70, P < 0.001), and 0.028 (when fixing pain persistence_early, t = 12.88, P = 0.395) (Fig 4). The results of these simulations suggest that approximately 7% of the βdisabilityearlydepressearly effect flowed through the pathway from fear-to-pain persistence-to-anxiety (Fig 4A), approximately 17% of the effect flowed through the pathway from LBP-to-pain persistence-to-anxiety (Fig 4B), and approximately 38% of the effect flowed through the pathway from pain persistence-to-anxiety (Fig 4C). The remaining 38% of the βdisabilityearlydepressearly effect was attributable to the direct effect of disability on depression.

Fig 3. Posterior samples (104) of the relationship between an early change in disability against an early change in depressive symptoms, with associated linear relationship.

Fig 3

Fig 4. Contribution of different pathways from early change in disability to early change in depressive symptoms.

Fig 4

A dotted arc (-—>) reflects a simulation whereby the “child” variable was made independent of its “parent”, meaning it is removed. Arrows in red reflect the arcs which are “removed” as a consequence of the aforementioned simulation. Information can only pass through grey arcs (not red). (a) scenario where early change in fear was independent of early change in disability, (b) scenario where early change in persistence was independent of early change in disability and low back pain. Abbreviation: Suffix with “_early”–change score between baseline and week-10 follow-up; “_late”–change value between week-10 and week-52; Anx—anxiety; lbp–low back pain.

Relationship between early and late change scores of each variable

It can be observed from Fig 2 that there is a negative relationship between the early and late change scores of the same variable. For example, a one-unit early reduction in LBP was associated with 0.43 lesser unit reduction in late LBP change score (t = -51.33, P < 0.001) (Fig 5). That is, participants who experienced substantial early reduction in LBP during treatment (between baseline and 10-week follow-up) tended to achieve smaller additional improvement in their LBP after discharge (between 10-weeks and 52-weeks).

Fig 5. Posterior samples (104) of the relationship between an early change in disability against an early change in depressive symptoms, with associated linear relationship.

Fig 5

Discussion

This is the first study to adopt a data-driven modelling approach to evaluate how individualised physiotherapy works (relative to advice) to help people with LBP. We found that individualised physiotherapy directly reduced disability and pain coping during the intervention period, with early change in disability subsequently facilitating changes in LBP intensity, recovery expectations, sleep, fear, anxiety and depression. We found that early improvement in disability led to early reduction in depression both directly and via more complex pathways involving fear, recovery expectations, anxiety, and LBP intensity. Our findings suggest that individualised physiotherapy treatment effects involve complex interactions between multiple variables that are mainly influential during the intervention period.

The finding that changes in pain and psychosocial variables such as fear, anxiety and depression were dependent on an early change in disability is in contrast to previous studies exploring individualised or stratified physiotherapy [17, 18], as well as the wider literature [45]. Mediation studies to date in the LBP field have tended to use hypothesis-driven modelling techniques which require a model structure to be imposed on the data. As disability is a common primary outcome measure in LBP clinical trials, it has typically been modelled as an “outcome” in mediation studies, hence being dependent on changes in psychosocial variables [17, 18]. It is not implausible that improvement in disability could lead to improvement in psychosocial variables, and that was the finding that emerged from our BN model which did not impose a fixed structure on variables. Other research has pointed to the potential for a reciprocal relationship between depression and pain severity in LBP [46], suggesting that the direction of association between variables may not be straightforward.

Apart from two early change variables (disability and anxiety), the relationships uncovered between early and late change indices were predominantly auto-correlations (i.e. early change was inversely associated with late change of the same variable) (Fig 2). Participants with large early improvements in variables between baseline and 10 weeks (the end of treatment) tended to achieve smaller additional improvements following discharge between 10–52 weeks. This finding could have two explanations. It could be that having achieved substantial recovery in the first 10 weeks there was little remaining scope for further improvement in fast-responding participants. Participants who received individualised physiotherapy experienced the greatest benefit within the 10 week treatment period (S2 Fig). It could also suggest that participants less responsive to treatment in the early stages achieved further gradual recovery after discharge–evidenced more clearly in the advice group (S2 Fig). Given that there were no direct influences of group on late change variables, it is likely that the later improvements in the advice group could be attributed to natural recovery (i.e. auto-correlations). These findings could alternatively suggest that strategies to maintain progress and motivation in participants after significant early improvement could be beneficial–such as booster sessions after discharge or preparing participants for long-term independent self-management to ensure ongoing progress [47].

The sequential pathway of the fear-avoidance model (FAM) formulated by Vlaeyen et al. [19] would predict that a change in fear would drive a later change in anxiety, and an even later change in depression. In the present study, only one relationship from the FAM (early anxiety-to-late depression) was found. It is possible that more relationships between the change values of different variables at different times could be due to the assessment intervals being too long [48]. For example, it is quite reasonable to expect that fluctuations in fear alters anxiety levels within a short timeframe (e.g. hours or even minutes). This means that the relatively long assessment intervals in the current study could largely contain auto-correlations, rather than temporal relations between variables [49]. Future studies may benefit from more frequent data collection strategies, such as daily text messages [50], to more accurately account for the temporal dependency of the modelled variables.

This study had several strengths. First, the data for the BN analysis was obtained from a robustly conducted, large RCT, with 96% of the original cohort included in the present analysis. This is in contrast to previous mediation studies with either a smaller sample size [40], or where the number of drop-outs was high (e.g. up to 37% [17]). Secondly, we report the full codes used in the present analysis, which provides reporting transparency. Third, we discovered some novel recovery pathways that have not been previously investigated in mediation studies, such as pain being dependent on disability and anxiety being dependent on pain intensity.

Despite its strengths, this study is not without limitations. We first note that methods to quantify pathways of change (i.e. causal inference) is not a singular method of scientific query, but actually comprise three hierarchical levels [51]–association (i.e. “how are the variables related?”), intervention (i.e. “what would Y be if I do X?”), and lastly counterfactuals (i.e. “What if I had acted differently?”). Each ladder provides an incremental amount of evidence towards causal inference. Many hypothesis-driven causal mediation analysis methods, as used in contemporary mediation studies [17, 44], operate at the level of counterfactual analysis. The current BN analysis can only act on the first and second rung (via our simulated intervention analysis) of the causation ladder, meaning that we cannot definitively conclude our uncovered pathways are causal. Despite an inability to perform counterfactual analysis, the present analysis could be said to provide competing, and potentially more probable, pathways of effect than those presented in the mediation literature, but this requires future confirmatory research. Another limitation of the present study was that BN model performance ranged from low to high. The lower performance for some variables such as work expectation and pain coping could indicate that there are potentially important factors that influence these variables missing from the current analysis. The STOPS trial prognostic study [52] showed that a range of biological factors were important predictors of outcome (eg. inflammatory indicators, motor control patterns, and range-of-motion measures), but these variables were only measured at baseline preventing the evaluation of their role as potentially important mechanisms operating between measured variables in the current study. For example, our model cannot exclude the possibility that individualised physiotherapy improved disability via latent mechanisms that were not measured in the current study (such as tissue healing or reduced inflammation). Including a wider range of biopsychosocial factors into the BN analysis may improve the overall network model’s correlation performance.

Conclusions

A data-driven BN modelling approach showed that individualised physiotherapy directly reduced disability and pain coping during the intervention period in people with low back pain. The effects of individualised physiotherapy on pain intensity, recovery expectations, sleep, fear, anxiety and depression were all exerted via an early change in disability. Early improvement in disability led to early reduction in depression both directly and via more complex pathways involving fear, recovery expectations, anxiety and LBP intensity. The effects of individualised physiotherapy on the investigated variables were most influential during the intervention period (0–10 weeks). Our findings suggest that the pathways to recovery from LBP in people receiving individualised physiotherapy are complex and multifactorial. Future RCTs could consider measuring a broad range of potential biopsychosocialvariables to facilitate BN analysis which is well suited to exploring complex inter-relationships between multiple variables.

Supporting information

S1 Fig. Percentage (out of n = 289 participants) missing data for each of the unfolded variables included in the Bayesian Network.

Abbreviation: Suffix with “_early”–change score between baseline and week-10 follow-up; “_late”–change value between week-10 and week-52;Anx—anxiety; grp–group; lbp–low back pain; lp–leg pain.

(TIFF)

S2 Fig. Mean with error bars as one standard deviation of the original values of each modelled variables in the Bayesian Network at each follow up time point.

Abbreviation: Anx—anxiety; lbp–low back pain; lp–leg pain; IndvPT–individualized physiotherapy.

(TIFF)

Acknowledgments

The authors wish to acknowledge the trial physiotherapists who volunteered to treat participants in this trial free of charge.

Data Availability

Data Available from: https://bernard-liew.github.io/2020_LBPcausal/index.html. Additionally, participants from the study provided informed consent that their data would only be made available to other researchers on specific requests to Dr. Ford or Dr. Hahne. We are therefore unable to publicly publish the dataset from this study, but reasonable requests to access the data can be directed either to the authors or alternatively to: Senior Manager, Ethics, Integrity and Biosafety Human Ethics Committee La Trobe University Telephone: +61 3 9479 1443 Email: humanethics@latrobe.edu.au Quote ethics ID: FHEC08/196.

Funding Statement

LifeCare Health provided facilities, personnel and resources to allow treatment of trial participants free of charge in the STOPS Trial.

References

  • 1.Mansell G, Kamper SJ, Kent P. Why and how back pain interventions work: What can we do to find out? Best Pract Res Clin Rheumatol. 2013;27:685–697. doi: 10.1016/j.berh.2013.10.001 [DOI] [PubMed] [Google Scholar]
  • 2.Hodges PW. Hybrid Approach to Treatment Tailoring for Low Back Pain: A Proposed Model of Care. J Orthop Sports Phys Ther. 2019;49:453–463. doi: 10.2519/jospt.2019.8774 [DOI] [PubMed] [Google Scholar]
  • 3.Huijnen IP, Rusu AC, Scholich S, Meloto C, Diatchenko L. Subgrouping of Low Back Pain Patients for Targeting Treatments: Evidence from Genetic, Psychological and Activity-related Behavioral Approaches. Clin J Pain. 2015;31:123–132. doi: 10.1097/AJP.0000000000000100 [DOI] [PubMed] [Google Scholar]
  • 4.Viswanathan VK, Shetty AP, Rajasekaran S. Modic changes—An evidence-based, narrative review on its patho-physiology, clinical significance and role in chronic low back pain. J Clin Orthop Trauma. 2020;11:761–769. doi: 10.1016/j.jcot.2020.06.025 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Kelly GA, Blake C, Power CK, OʼKeeffe D, Fullen BM. The Association Between Chronic Low Back Pain and Sleep. Clin J Pain. 2011;27:169–181. doi: 10.1097/AJP.0b013e3181f3bdd5 [DOI] [PubMed] [Google Scholar]
  • 6.Hallegraeff JM, Kan R, Van Trijffel E, Reneman MF. State anxiety improves prediction of pain and pain-related disability after 12 weeks in patients with acute low back pain: a cohort study. J Physiother. 2020;66:39–44. doi: 10.1016/j.jphys.2019.11.011 [DOI] [PubMed] [Google Scholar]
  • 7.Wertli MM, Eugster R, Held U, Steurer J, Kofmehl R, Weiser S. Catastrophizing-a prognostic factor for outcome in patients with low back pain: a systematic review. Spine J. 2014;14:2639–2657. doi: 10.1016/j.spinee.2014.03.003 [DOI] [PubMed] [Google Scholar]
  • 8.Costa-Black KM, Loisel P, Anema JR, Pransky G. Back pain and work. Best Pract Res Clin Rheumatol. 2010;24:227–240. doi: 10.1016/j.berh.2009.11.007 [DOI] [PubMed] [Google Scholar]
  • 9.Foster NE, Anema JR, Cherkin D, Chou R, Cohen SP, Gross DP, et al. Prevention and treatment of low back pain: evidence, challenges, and promising directions. Lancet. 2018;391:2368–2383. doi: 10.1016/S0140-6736(18)30489-6 [DOI] [PubMed] [Google Scholar]
  • 10.Oliveira CB, Maher CG, Pinto RZ, Traeger AC, Lin C-WC, Chenot J-F, et al. Clinical practice guidelines for the management of non-specific low back pain in primary care: an updated overview. Eur Spine J. 2018;27:2791–2803. doi: 10.1007/s00586-018-5673-2 [DOI] [PubMed] [Google Scholar]
  • 11.O’Sullivan K, O’Sullivan P, Vibe Fersum K, Kent P. Better targeting care for individuals with low back pain: opportunities and obstacles. BJSM. 2017;51:489–490. doi: 10.1136/bjsports-2016-096612 [DOI] [PubMed] [Google Scholar]
  • 12.Ford J, Hahne A, Surkitt L, Chan A, Richards M. The Evolving Case Supporting Individualised Physiotherapy for Low Back Pain. J Clin Med. 2019;8. doi: 10.3390/jcm8091334 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Hill JC, Whitehurst DG, Lewis M, Bryan S, Dunn KM, Foster NE, et al. Comparison of stratified primary care management for low back pain with current best practice (STarT Back): a randomised controlled trial. Lancet. 2011;378:1560–1571. doi: 10.1016/S0140-6736(11)60937-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.O’Keeffe M, O’Sullivan P, Purtill H, Bargary N, O’Sullivan K. Cognitive functional therapy compared with a group-based exercise and education intervention for chronic low back pain: a multicentre randomised controlled trial (RCT). BJSM. 2020;54:782–789. doi: 10.1136/bjsports-2019-100780 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Vibe Fersum K, O’Sullivan P, Skouen JS, Smith A, Kvale A. Efficacy of classification-based cognitive functional therapy in patients with non-specific chronic low back pain: a randomized controlled trial. Eur J Pain. 2013;17:916–928. doi: 10.1002/j.1532-2149.2012.00252.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Ford JJ, Hahne AJ, Surkitt LD, Chan AY, Richards MC, Slater SL, et al. Individualised physiotherapy as an adjunct to guideline-based advice for low back disorders in primary care: a randomised controlled trial. BJSM. 2016;50:237–245. doi: 10.1136/bjsports-2015-095058 [DOI] [PubMed] [Google Scholar]
  • 17.O’Neill A, O’Sullivan K, O’Sullivan P, Purtill H, O’Keeffe M. Examining what factors mediate treatment effect in chronic low back pain: A mediation analysis of a Cognitive Functional Therapy clinical trial. Eur J Pain. 2020;24:1765–1774. doi: 10.1002/ejp.1624 [DOI] [PubMed] [Google Scholar]
  • 18.Mansell G, Hill JC, Main C, Vowles KE, van der Windt D. Exploring What Factors Mediate Treatment Effect: Example of the STarT Back Study High-Risk Intervention. J Pain. 2016;17:1237–1245. doi: 10.1016/j.jpain.2016.08.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Leeuw M, Goossens ME, Linton SJ, Crombez G, Boersma K, Vlaeyen JW. The fear-avoidance model of musculoskeletal pain: current state of scientific evidence. J Behav Med. 2007;30:77–94. doi: 10.1007/s10865-006-9085-0 [DOI] [PubMed] [Google Scholar]
  • 20.Nagarajan R, Scutari M, Lèbre S. Bayesian networks in R with applications in systems biology. Verlag, New York: Springer; 2013. [Google Scholar]
  • 21.Fordham B, Ji C, Hansen Z, Lall R, Lamb SE. Explaining How Cognitive Behavioral Approaches Work for Low Back Pain: Mediation Analysis of the Back Skills Training Trial. Spine (Phila Pa 1976). 2017;42:E1031–e1039. doi: 10.1097/BRS.0000000000002066 [DOI] [PubMed] [Google Scholar]
  • 22.Liew BXW, Scutari M, Peolsson A, Peterson G, Ludvigsson ML, Falla D. Investigating the Causal Mechanisms of Symptom Recovery in Chronic Whiplash-associated Disorders Using Bayesian Networks. Clin J Pain. 2019;35:647–655. doi: 10.1097/AJP.0000000000000728 [DOI] [PubMed] [Google Scholar]
  • 23.Liew BXW, Peolsson A, Scutari M, Löfgren H, Wibault J, Dedering Å, et al. Probing the mechanisms underpinning recovery in post-surgical patients with cervical radiculopathy using Bayesian networks. Eur J Pain. 2020;24:909–920. doi: 10.1002/ejp.1537 [DOI] [PubMed] [Google Scholar]
  • 24.Hahne AJ, Ford JJ, Surkitt LD, Richards MC, Chan AY, Thompson SL, et al. Specific treatment of problems of the spine (STOPS): design of a randomised controlled trial comparing specific physiotherapy versus advice for people with subacute low back disorders. BMC Musculoskelet Disord. 2011;12:104. doi: 10.1186/1471-2474-12-104 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Indahl A, Velund L, Reikeraas O. Good prognosis for low back pain when left untampered. A randomized clinical trial. Spine (Phila Pa 1976). 1995;20:473–477. doi: 10.1097/00007632-199502001-00011 [DOI] [PubMed] [Google Scholar]
  • 26.Ford JJ, Hahne AJ, Chan AYP, Surkitt LD. A classification and treatment protocol for low back disorders: Part 3- Functional restoration for intervertebral disc related problems. Phys Ther Rev. 2012;17:55–75. [Google Scholar]
  • 27.Ford JJ, Richards MC, Hahne AJ. A classification and treatment protocol for low back disorders: Part 4- Functional restoration for multi-factorial persistent pain. Phys Ther Rev. 2012;17:322–334. [Google Scholar]
  • 28.Ford JJ, Surkitt LD, Hahne AJ. A classification and treatment protocol for low back disorders: Part 2- Directional preference management for reducible discogenic pain. Phys Ther Rev. 2011;16:423–437. [Google Scholar]
  • 29.Ford JJ, Thompson SL, Hahne AJ. A classification and treatment protocol for low back disorders: Part 1- Specific manual therapy. Phys Ther Rev. 2011;16:168–177. [Google Scholar]
  • 30.Linton SJ, Boersma K. Early identification of patients at risk of developing a persistent back problem: the predictive validity of the Orebro Musculoskeletal Pain Questionnaire. Clin J Pain. 2003;19:80–86. doi: 10.1097/00002508-200303000-00002 [DOI] [PubMed] [Google Scholar]
  • 31.Nielsen AM, Vach W, Kent P, Hestbaek L, Kongsted A. Using existing questionnaires in latent class analysis: should we use summary scores or single items as input? A methodological study using a cohort of patients with low back pain. Clin Epidemiol. 2016;8:73–89. doi: 10.2147/CLEP.S103330 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.da Silva T, Macaskill P, Kongsted A, Mills K, Maher CG, Hancock MJ. Predicting pain recovery in patients with acute low back pain: Updating and validation of a clinical prediction model. Eur J Pain. 2019;23:341–353. doi: 10.1002/ejp.1308 [DOI] [PubMed] [Google Scholar]
  • 33.Kent P, Mirkhil S, Keating J, Buchbinder R, Manniche C, Albert HB. The concurrent validity of brief screening questions for anxiety, depression, social isolation, catastrophization, and fear of movement in people with low back pain. Clin J Pain. 2014;30:479–489. doi: 10.1097/AJP.0000000000000010 [DOI] [PubMed] [Google Scholar]
  • 34.McWilliams LA, Sarty G, Kowal J, Wilson KG. A Network Analysis of Depressive Symptoms in Individuals Seeking Treatment for Chronic Pain. Clin J Pain. 2017;33:899–904. doi: 10.1097/AJP.0000000000000477 [DOI] [PubMed] [Google Scholar]
  • 35.Borsboom D, Cramer AO. Network analysis: an integrative approach to the structure of psychopathology. Annu Rev Clin Psychol. 2013;9:91–121. doi: 10.1146/annurev-clinpsy-050212-185608 [DOI] [PubMed] [Google Scholar]
  • 36.Fairbank JC, Pynsent PB. The Oswestry Disability Index. Spine (Phila Pa 1976). 2000;25:2940–2952. doi: 10.1097/00007632-200011150-00017 [DOI] [PubMed] [Google Scholar]
  • 37.Scutari M. Learning Bayesian Networks with the bnlearn R Package. J Stat Softw. 2010;35:22. [Google Scholar]
  • 38.Liew BXW, Ford J, Scutari M, Hahne AJ. Codes to the paper "How does individualised physiotherapy work for people with low back pain? A Bayesian Network analysis using randomised controlled trial data". Available from: https://bernard-liew.github.io/2020_LBPcausal/index.html 2020. Available from: Available from: https://bernard-liew.github.io/2020_LBPcausal/index.html [DOI] [PMC free article] [PubMed]
  • 39.Friedman N. Learning Belief Networks in the Presence of Missing Values and Hidden Variables. Proceedings of the Fourteenth International Conference on Machine Learning. 657145: Morgan Kaufmann Publishers Inc.; 1997. p. 125–133.
  • 40.Costa Lda C, Maher CG, McAuley JH, Hancock MJ, Smeets RJ. Self-efficacy is more important than fear of movement in mediating the relationship between pain and disability in chronic low back pain. Eur J Pain. 2011;15:213–219. doi: 10.1016/j.ejpain.2010.06.014 [DOI] [PubMed] [Google Scholar]
  • 41.Scutari M, Nagarajan R. Identifying significant edges in graphical models of molecular networks. Artif Intell Med. 2013;57:207–217. doi: 10.1016/j.artmed.2012.12.006 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Hinkle D, Wiersma W, Jurs S. Applied Statistics for the Behavioral Sciences. 5 ed. Boston: Houghton Mifflin; 2003. [Google Scholar]
  • 43.Hughes RA, Heron J, Sterne JAC, Tilling K. Accounting for missing data in statistical analyses: multiple imputation is not always the answer. Int J Epidemiol. 2019;48:1294–1304. doi: 10.1093/ije/dyz032 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Williams A, Lee H, Kamper SJ, O’Brien KM, Wiggers J, Wolfenden L, et al. Causal mechanisms of a healthy lifestyle intervention for patients with musculoskeletal pain who are overweight or obese. Clin Rehabil. 2019:269215519831419. [DOI] [PubMed] [Google Scholar]
  • 45.Lee H, Hubscher M, Moseley GL, Kamper SJ, Traeger AC, Mansell G, et al. How does pain lead to disability? A systematic review and meta-analysis of mediation studies in people with back and neck pain. Pain. 2015;156:988–997. doi: 10.1097/j.pain.0000000000000146 [DOI] [PubMed] [Google Scholar]
  • 46.Elfering A, Käser A, Melloh M. Relationship between depressive symptoms and acute low back pain at first medical consultation, three and six weeks of primary care. Psychol Health Med. 2014;19:235–246. doi: 10.1080/13548506.2013.780131 [DOI] [PubMed] [Google Scholar]
  • 47.Beattie PF, Silfies SP. Improving Long-Term Outcomes for Chronic Low Back Pain: Time for a New Paradigm? Journal of Orthopaedic & Sports Physical Therapy. 2015;45:236–239. doi: 10.2519/jospt.2015.0105 [DOI] [PubMed] [Google Scholar]
  • 48.Wideman TH, Adams H, Sullivan MJL. A prospective sequential analysis of the fear-avoidance model of pain. Pain. 2009;145:45–51. doi: 10.1016/j.pain.2009.04.022 [DOI] [PubMed] [Google Scholar]
  • 49.Epskamp S, van Borkulo CD, van der Veen DC, Servaas MN, Isvoranu A-M, Riese H, et al. Personalized Network Modeling in Psychopathology: The Importance of Contemporaneous and Temporal Connections. Clin Psychol Sci. 2018;6:416–427. doi: 10.1177/2167702617744325 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Burström L, Jonsson H, Björ B, Hjalmarsson U, Nilsson T, Reuterwall C, et al. Daily text messages used as a method for assessing low back pain among workers. J Clin Epidemiol. 2016;70:45–51. doi: 10.1016/j.jclinepi.2015.08.011 [DOI] [PubMed] [Google Scholar]
  • 51.Pearl J, Mackenzie D. The Ladder of Causation. The Book of Why The New Science of Cause and Effect. New York: Allen Lane; 2018. p. 32. [Google Scholar]
  • 52.Ford JJ, Richards MC, Surkitt LD, Chan AYP, Slater SL, Taylor NF, et al. Development of a Multivariate Prognostic Model for Pain and Activity Limitation in People With Low Back Disorders Receiving Physiotherapy. Arch Phys Med Rehabil. 2018;99:2504-2512.e2512. doi: 10.1016/j.apmr.2018.04.026 [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Walid Kamal Abdelbasset

26 Aug 2021

PONE-D-21-22271

Using data-driven Bayesian Network analysis to explore recovery pathways in people with low back pain receiving individualised physiotherapy or advice

PLOS ONE

Dear Dr. Liew,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Oct 10 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Walid Kamal Abdelbasset, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. Please provide additional details regarding participant consent. In the Methods section, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information.

3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: No

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This manuscript requires a significant amount of improvement in:

Title

1. Title needs to be modified.

2. Kindly frame title such that it is accurate, informative, descriptive, succinct, simple and specific.

3. Kindly avoid the words like

Abstract:

1. Trial design is not mentioned.

2. The background needs to be shortened.

3. Methods section is poorly framed. It has to be re-written.

4. Demographic profile of patients is not mentioned.

Introduction: please follow these steps to have scientific introduction

1. Explain the rationale of the study. Please delete information unrelated to objective so that the section is short and sweet. For example, the first page of introduction may be deleted. Kindly focus on three elements of introduction.

a. What is known about the topic? (Background)

b. What is not known? (The research problem)

c. Why the study was done? (Justification)

2. Objective is not clear as mentioned above.

1. Methods section determines the results. Kindly focus on three basic elements of methods section.

a. How the study was designed?

b. How the study was carried out?

c. How the data were analyzed?

d. Components of methods

i. Study design, setting, sample size

ii. Participant

iii. Intervention/issue of interest (exposure)

iv. Comparison

v. Ethics and end point

vi. Statistical analysis

1. The discussion section needs to be described scientifically. Kindly frame it along the following lines:

i. Main findings of the present study

ii. Comparison with other studies

iii. Implication and explanation of findings

iv. Strengths and limitations need to be clear

v. Conclusion, recommendation and future direction.

Reviewer #2: The authors conduct a Bayesian Network approach to model the recovery pathways in 300 people with low back pain receiving individualized physiotherapy or advice from a randomized controlled trial. The results showed that individualized physiotherapy reduced early improvement in disability and its relevant consequences.

1. Variables included in the Bayesian Network. Was sample characteristic information (e.g. age, sex, and so on) included, either as nodes or adjusted, in the Network construction as these information may play an important role?

2. Please comment on whether the missingness behave differently for the participants in two different groups.

3. Table 2. Correlation was reported. What measure of correlation was reported? If Pearson correlation was reported, were the data normally distributed?

4. Please comment on how the directions were decided. Any potential misspecification or reciprocal relationship? If so, how these may affect the results?

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2021 Oct 11;16(10):e0258515. doi: 10.1371/journal.pone.0258515.r002

Author response to Decision Letter 0


7 Sep 2021

Please see the uploaded Response to Reviewers document for a proper view of our detailed reply, which includes tables, figures with the appropriate formatting.

Editor

Thank-you for the opportunity to revise our manuscript for PLOS ONE. We have carefully addressed the comments of the editor and the two reviewers, and feel confident that the manuscript has been enhanced by these recommendations.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming.

Reply: We have checked the manuscript against the PLOS ONE style requirements and believe it is compliant.

2. Please provide additional details regarding participant consent. In the Methods section, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal).

Reply: Further information around consent of participants has been added to the manuscript as per the text below (L97):

All participants provided written informed consent to participate in the trial.

3. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

Reply: Participants from the study provided informed consent that their data would only be made available to other researchers on specific request to Dr. Ford or Dr. Hahne. We are therefore unable to publicly publish the dataset from this study, but reasonable requests to access the data can be directed either to the authors, or alternatively to:

Senior Manager, Ethics, Integrity and Biosafety

Human Ethics Committee

La Trobe University

Telephone: +61 3 9479 1443

Email: humanethics@latrobe.edu.au

Quote ethics ID: FHEC08/196

Once again, than-you for the opportunity to revise our paper for PLOS ONE.

Reviewer #1:

This manuscript requires a significant amount of improvement in:

Title

1. Title needs to be modified.

Reply: The title has been completely re-written

Changed from: Using data-driven Bayesian Network analysis to explore recovery pathways in people with low back pain receiving individualised physiotherapy or advice.

Changed to: How does individualised physiotherapy work for people with low back pain? A Bayesian Network analysis using randomised controlled trial data.

2. Kindly frame title such that it is accurate, informative, descriptive, succinct, simple and specific.

Reply: We thank the Reviewer for this specific suggestion. The new title as presented above has attempted to address these criteria.

3. Kindly avoid the words like

Reply: The comment was incomplete, but as the title has been completely re-written we hope the concern has been addressed.

Abstract:

1. Trial design is not mentioned.

Reply: We thank the Reviewer for this observation. The trial design has been added to the abstract using the following text (L22):

We sought to determine how this treatment works by using randomised controlled trial data to develop a Bayesian Network model.

2. The background needs to be shortened.

Reply: We thank the Reviewer for their suggestion. We have shortened the background in the Abstract to comprise two short sentences as indicated below (L21):

Individualised physiotherapy is an effective treatment for low back pain. We sought to determine how this treatment works by using randomised controlled trial data to develop a Bayesian Network model.

3. Methods section is poorly framed. It has to be re-written.

Reply: We have completely re-structured the methods section of the Abstract to make it clearer, incorporating information on participants, treatments, analysis approach, and what the data is able to explain (L24).

300 randomised controlled trial participants (153 male, 147 female, mean age 44.1) with low back pain (of duration 6-26 weeks) received either individualised physiotherapy or advice. Variables with potential to explain how individualised physiotherapy works were included in a multivariate Bayesian Network model. Modelling incorporated the intervention period (0-10 weeks after study commencement – “early” changes) and the followup period (10-52 weeks after study commencement – “late” changes). Sequences of variables in the Bayesian Network showed the most common direct and indirect recovery pathways followed by participants with low back pain receiving individualised physiotherapy or advice.

4. Demographic profile of patients is not mentioned.

Reply: This has been added to the methods section of the Abstract (L24):

300 randomised controlled trial participants (153 male, 147 female, mean age 44.1) with low back pain (of duration 6-26 weeks)…

Introduction: please follow these steps to have scientific introduction

1. Explain the rationale of the study. Please delete information unrelated to objective so that the section is short and sweet. For example, the first page of introduction may be deleted. Kindly focus on three elements of introduction.

a. What is known about the topic? (Background)

b. What is not known? (The research problem)

c. Why the study was done? (Justification)

Reply: We thank the Reviewer for their helpful suggestions to help focus the structure of our Introduction. We have re-written the Introduction to focus on 1) introducing the topic (how do low back pain treatments work), 2) presenting the limitations of previous research that has tried to answer this question, and establishing what questions remain unanswered, and 3) justification and objectives of the current study.

2. Objective is not clear as mentioned above.

Reply: As part of re-writing the Introduction, the objective of the study is now more clearly stated at the end of the introduction (L88).

The aim of this study was to determine how the individualised physiotherapy (relative to the advice) approach in the STOPS RCT helped people with LBP.

1. Methods section determines the results. Kindly focus on three basic elements of methods section.

a. How the study was designed?

b. How the study was carried out?

c. How the data were analyzed?

d. Components of methods

i. Study design, setting, sample size

ii. Participant

iii. Intervention/issue of interest (exposure)

iv. Comparison

v. Ethics and end point

vi. Statistical analysis

Reply: We thank the Reviewer for their recommendations for important elements to include in the Methods section. We have revised the manuscript to ensure that each suggested element is included. We have also checked recent articles in PLOS ONE to ensure consistency of structure and subheadings. Changes to the manuscript as a result of this restructuring are evident via tracked changes.

1. The discussion section needs to be described scientifically. Kindly frame it along the following lines:

i. Main findings of the present study

ii. Comparison with other studies

iii. Implication and explanation of findings

iv. Strengths and limitations need to be clear

v. Conclusion, recommendation, and future direction.

Reply: We thank the Reviewer again for outlining the important elements for Discussion. We have revised our manuscript to ensure that all suggested elements are addressed. However, given that we discuss three main points a slightly altered structure was chosen to the one suggested by the Reviewer so that each main point could be thoroughly discussed one at a time. The new structure involves:

Paragraph 1 summarises the main findings of the study from the results

Paragraph 2 discusses the first main finding in greater depth, including a comparison to other studies and explanation/implications of findings

Paragraph 3 discusses the second main finding in greater depth, including a comparison to other studies and explanation/implications of findings

Paragraph 4 discusses the third main finding in greater depth, including a comparison to other studies and explanation/implications of findings

Paragraph 5 discusses the strengths of the study

Paragraph 6 discusses the limitations of the study

Paragraph 7 concludes and makes recommendations for future research

We believe this structure flows logically, aligns with the order of the results presented, and is consistent with the structure of other recent articles published in PLOS ONE.

Reviewer #2

The authors conduct a Bayesian Network approach to model the recovery pathways in 300 people with low back pain receiving individualized physiotherapy or advice from a randomized controlled trial. The results showed that individualized physiotherapy reduced early improvement in disability and its relevant consequences.

1. Variables included in the Bayesian Network. Was sample characteristic information (e.g. age, sex, and so on) included, either as nodes or adjusted, in the Network construction as these information may play an important role?

Reply: We only included factors in the Bayesian Network that were potentially modifiable, as this would make them potentially useful therapeutic targets. Sample characteristics at baseline are not modifiable with treatment. In addition, our previous publications on the current data set show that there were no differences between treatment groups on any of the baseline sample characteristic (Ford et al. 2016), nor were these characteristics predictive of outcome (Ford et al 2018). However, we have also included the descriptive statistics of the baseline demographic characteristics in the revised Table 1, in response to the comment below.

We also ran an exploratory Bayesian Network analysis with the four demographic variables included, but found that these variables did not influence other variables (see image below). To create a simpler model, we excluded these four demographic variables during the formal analysis.

2. Please comment on whether the missingness behave differently for the participants in two different groups.

Reply: We thank the Reviewer for this comment. We have included in the revised Table 1, baseline descriptive characteristics for all participants, including the 11 that were excluded due to high missing data.

Table 1.Baseline descriptive characteristics of cohort included in Bayesian Network analysis

Baseline variable Advice (n = 137) Individualized PT (n = 152) Missing-excluded (n = 11) P.value

Age(years) 44.69(12.33) 42.67(12.02) 44.19(11.75) 0.368

Sex-Female* 67 74 6 0.931

Sex-Male* 70 78 5 0.931

Weight(kg) 77.41(15.79) 77.26(17.77) 174.38(6.07) 0.195

Height(cm) 169.97(11.52) 172.24(10.47) 74.7(8.93) 0.885

Disability 29.71(13.25) 29.31(11.85) 26.82(5.78) 0.750

Low back pain intensity 5.48(1.94) 5.29(1.97) 4.77(1.47) 0.415

Leg pain intensity 4.76(2.62) 4.58(2.74) 4.8(2.49) 0.860

Pain coping 5.06(2.15) 5.16(2.37) 4.36(2.38) 0.526

Anxiety 5.08(2.5) 4.62(2.58) 4(3.52) 0.183

Depression 3.54(2.98) 3.01(2.98) 3.64(3.5) 0.312

Pain persistence 7.26(2.17) 6.74(2.36) 6.55(3.17) 0.128

Work expectations 2.01(3.24) 1.63(2.95) 5.36(4.18) 0.001

Sleep 3.69(2.54) 3.57(2.49) 3.45(2.5) 0.893

Fear 18.11(6.01) 18.58(6.17) 22.6(6.13) 0.081

Abbreviations: PT - physiotherapy

* - variables represent counts of participants. All other values reflect mean (one standard deviation).

P values for continuous variables derived from a one-way Analysis of Variance test, count variable from a Chi-squared Test.

3. Table 2. Correlation was reported. What measure of correlation was reported? If Pearson correlation was reported, were the data normally distributed?

Reply: We thank the Reviewer for this comment. Yes, this was the Pearson correlation, and we edited the wording to reflect this change. The assumption of the normal distribution is really important only if the statistical inference of the correlation was undertaken – which we did not in the present project. Furthermore, we confirmed that the reported Pearson correlations are not inflated: both the observed and the predicted values are approximately symmetric and present little in the way of skewness. We also excluded inflation due to outliers by checking a plot of observed values against predicted values. In addition to the correlation values, we have included other traditional metrics of performance in linear regression modelling, such as root-mean-square error, mean square error, and mean absolute error (revised Table 2).

Table 2 Measurement errors between observed and predicted change values

Variable Correlation Correlation strength RMSE MSE MAE

disability_early 0.72 high 9.2 85.4 7.2

lbp_early 0.68 moderate 1.8 3.4 1.4

lp_early 0.71 high 1.9 3.5 1.4

pain_cope_early 0.52 moderate 2.6 7.2 2.1

sleep_early 0.53 moderate 1.9 3.8 1.5

work_expect_early 0.44 low 2.1 4.7 1.6

pain_persist_early 0.62 moderate 2.4 5.9 1.9

anx_early 0.76 high 2.0 4.4 1.2

depress_early 0.69 moderate 2.3 5.4 1.8

fear_early 0.55 moderate 5.7 32.1 4.3

disability_late 0.73 high 8.2 68.8 6.2

lbp_late 0.71 high 1.6 2.5 1.2

lp_late 0.70 moderate 1.7 3.1 1.2

pain_cope_late 0.46 low 2.6 6.8 1.8

sleep_late 0.59 moderate 1.7 3.1 1.2

work_expect_late 0.42 low 1.6 2.7 1.1

pain_persist_late 0.65 moderate 2.6 7.0 1.9

anx_late 0.74 high 1.9 4.0 1.0

depress_late 0.65 moderate 1.7 2.9 1.1

fear_late 0.53 moderate 5.0 25.4 3.8

Abbreviation: Abbreviation: Suffix with “_early” – change score between baseline and week-10 follow-up; “_late” – change value between week-10 and week-52; Anx - anxiety; lbp – low back pain; lp – leg pain; RMSE – root-mean-squared error; MSE- mean squared error; MAE- mean absolute error.

4. Please comment on how the directions were decided. Any potential misspecification or reciprocal relationship? If so, how these may affect the results?

Reply: We thank the Reviewer for this comment. Herein, we use the term “structural learning” to reflect learning the direction of relationships. We used the “hill-climbing” algorithm, which was embedded into structural expectation-maximization for structural learning. The hill-climbing algorithm uses a search strategy that explores the space of the directed acyclic graphs by single-arc addition, removal, and reversals (without introducing cycles into the graph); with random restarts to avoid local optima. The structure that maximizes the model fit to the data is retained.

Reciprocal, bidirectional, relationships are not permitted in a Bayesian Network model, because by definition, a Bayesian Network models an acyclic graph. Bidirectional relationships will introduce cycles into the model, something that is avoided in all structural learning algorithms for Bayesian Network. Note that cyclic and bidirectional/reciprocal relationships are forbidden in the Bayesian networks, in which the same variable is represented by different nodes at different time points; but they can still be read from the network if we consider variables after abstracting away time. For instance, in Figure 2 we can see the arcs anx_early -> depress_late and depress_early -> anx_late: these indicate a feedback loop in which anxiety feeds depression which in turn feeds anxiety.

Misspecification is possible if there are missing confounding variables. We have identified this as a potential study limitation in the Discussion of the Original manuscript. To further mitigate modelling biologically unrealistic relationships (e.g. if a variable at 12th month can influence another variable at baseline), we included a blacklist into the model, so that such relationships are enforced during model building.

Attachment

Submitted filename: ReplyReview_R1_v2.docx

Decision Letter 1

Walid Kamal Abdelbasset

29 Sep 2021

How does individualised physiotherapy work for people with low back pain? A Bayesian Network analysis using randomised controlled trial data

PONE-D-21-22271R1

Dear Dr. Liew,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Walid Kamal Abdelbasset, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: (No Response)

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Acceptance letter

Walid Kamal Abdelbasset

1 Oct 2021

PONE-D-21-22271R1

How does individualised physiotherapy work for people with low back pain? A Bayesian Network analysis using randomised controlled trial data.  

Dear Dr. Liew:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Walid Kamal Abdelbasset

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Percentage (out of n = 289 participants) missing data for each of the unfolded variables included in the Bayesian Network.

    Abbreviation: Suffix with “_early”–change score between baseline and week-10 follow-up; “_late”–change value between week-10 and week-52;Anx—anxiety; grp–group; lbp–low back pain; lp–leg pain.

    (TIFF)

    S2 Fig. Mean with error bars as one standard deviation of the original values of each modelled variables in the Bayesian Network at each follow up time point.

    Abbreviation: Anx—anxiety; lbp–low back pain; lp–leg pain; IndvPT–individualized physiotherapy.

    (TIFF)

    Attachment

    Submitted filename: ReplyReview_R1_v2.docx

    Data Availability Statement

    Data Available from: https://bernard-liew.github.io/2020_LBPcausal/index.html. Additionally, participants from the study provided informed consent that their data would only be made available to other researchers on specific requests to Dr. Ford or Dr. Hahne. We are therefore unable to publicly publish the dataset from this study, but reasonable requests to access the data can be directed either to the authors or alternatively to: Senior Manager, Ethics, Integrity and Biosafety Human Ethics Committee La Trobe University Telephone: +61 3 9479 1443 Email: humanethics@latrobe.edu.au Quote ethics ID: FHEC08/196.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES